Morepen lab share price

STOCK SUMMARY • Face Value (₹) 2.00 • Beta 0.27 • 52-Week Low (₹) 23.60 • 52-Week High (₹) 48.45 • Price-to-Book (X)* 1.98 • Dividend Yield (%) 0.00 • Price-to-Earnings (P/E) (X)* 38.42 • Earnings Per Share (₹) 0.76 • Sector Price Earning (X)* 30.49 • Market Cap (₹ Cr.)* 1,492.61 • * Vaues as of last close price COMPETITORS • Zydus Lifesciences ₹551.05 1.90 (0.35%) • Glaxosmithkline Pharmaceuticals ₹1,419.20 17.70 (1.26%) • Divis Laboratories ₹3,579.60 -1.45 (0.04%) • Sun Pharmaceuticals Industries ₹992.00 3.60 (0.36%) • Syngene International ₹742.40 -7.25 (0.97%) • Dr Reddys Laboratories ₹4,915.05 111.60 (2.32%) • Biocon ₹244.90 1.40 (0.57%) The peers of Morepen Laboratories Ltd are Zydus Lifesciences Ltd, Glaxosmithkline Pharmaceuticals Ltd, Divis Laboratories Ltd, Sun Pharmaceuticals Industries Ltd, Syngene International Ltd, Dr Reddys Laboratories Ltd, Biocon Ltd, Lupin Ltd, Aurobindo Pharma Ltd, Ajanta Pharma Ltd, Cipla Ltd, Laurus Labs Ltd, Torrent Pharmaceuticals Ltd, Alkem Laboratories Ltd. Morepen Laboratories Ltd, incorporated in the year 1984, has its registered office in Morepen Village, Nalagarh Road Near Baddi, Solan, Himachal Pradesh, 173205, 91-01795-276201-03, 91-01795-276204. The main industry in which Morepen Laboratories Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln. Auditor/Auditors for Morepen Laboratories Ltd is/are Satinder Goyal & Co/S P Babuta & Associates. In the main management, Sushil Suri is chairman and Vipul Kumar Srivatava ...

• Stock Returns vs Nifty Smallcap 100 Stock gave a 3 year return of -8.46% as compared to Nifty Smallcap 100 which gave a return of 141.48%. (as of last trading session) • Stock Returns vs Nifty Pharma Stock generated -8.46% return as compared to Nifty Pharma which gave investors 32.58% return over 3 year time period. (as of last trading session) NAME P/E (x) P/B (x) ROE % ROCE % ROA % Rev CAGR [3Yr] OPM NPM Basic EPS Current Ratio Total Debt/ Equity (x) Total Debt/ CFO (x) 38.59 1.98 5.13 7.31 3.48 17.98 4.07 2.72 0.77 2.35 0.03 0.00 28.19 6.46 22.91 20.06 9.25 21.46 16.64 11.54 8.22 1.61 0.90 0.00 19.75 2.63 13.32 14.22 10.51 -2.68 30.92 27.29 41.86 4.25 0.00 0.00 -66.19 0.34 -0.51 1.03 -0.31 5.28 3.28 -1.23 -1.90 1.07 0.31 0.00 -15.74 2.53 -17.33 -3.72 -7.92 6.20 -2.62 -8.58 -4.88 1.50 0.57 0.00 Add More • Stock Returns vs Nifty Smallcap 100 Stock gave a 3 year return of -8.46% as compared to Nifty Smallcap 100 which gave a return of 141.48%. (as of last trading session) • Stock Returns vs Nifty Pharma Stock generated -8.46% return as compared to Nifty Pharma which gave investors 32.58% return over 3 year time period. (as of last trading session) Meeting Date Announced on Purpose Details May 16, 2023 May 09, 2023 Board Meeting Audited Results Feb 13, 2023 Feb 06, 2023 Board Meeting Quarterly Results Nov 10, 2022 Nov 03, 2022 Board Meeting Quarterly Results Jul 29, 2022 Jul 22, 2022 Board Meeting Quarterly Results May 05, 2022 Apr 28, 2022 Board Meeting Audited Results •...

Morepen Laboratories Ltd. engages in the manufacture and market of bulk drugs and pharmaceutical formulations. It operates through the following business segments: Global Generics, Finished Formulations, Home Health, and Dr. Morepen. The company was founded by K.B. Suri on December 1, 1984 and is headquartered in New Delhi, India. Morepenlab has given a breakout above a very important recent high with good strong volumes in a very bearish market. It may have legs to go till 52-53 in the coming weeks. The high of the current daily candle needs to break first. Disclaimer - Not a trading advice or buy/sell call, only for edu Morepenlab has given a breakout above a very important recent high with good strong volumes in a very bearish market. It may have legs to go till 52-53 in the coming weeks. The high of the current daily candle needs to break first. Disclaimer - Not a trading advice or buy/sell call, only for edu #MOREPENLAB NSE: MOREPENLAB CMP 31.70 Target 42+ SL 27.5 RR >2.5 times Return > 30% Timeframe 2.5 times Return > 30% Timeframe < 6M NSE:MOREPENLAB Factors: BULLISH WEDGE BREAKOUT Trend Following Rising Volume with rising Prices. Flag pattern breakout. Pennant Pattern Breakout with Bullish Candle. Retest Successful. Higher H

16 Jun 29.20 (-3.95%) 15 Jun 30.40 (9.35%) 14 Jun 27.80 (0.54%) 13 Jun 27.65 (2.22%) 12 Jun 27.05 (0.00%) 09 Jun 27.05 (0.37%) 08 Jun 26.95 (-0.55%) 07 Jun 27.10 (-0.18%) 06 Jun 27.15 (0.00%) 05 Jun 27.15 (3.04%) 02 Jun 26.35 (0.38%) 01 Jun 26.25 (2.14%) 31 May 25.70 (0.39%) 30 May 25.60 (0.59%) 29 May 25.45 (0.00%) 26 May 25.45 (-0.39%) 25 May 25.55 (-0.39%) 24 May 25.65 (-0.39%) 23 May 25.75 (0.19%) 22 May 25.70 (-0.77%) 19 May 25.90 (-0.77%) Intraday Support and Resistance (Based on Pivot Points) | Updated On Jun 16, 2023 04:00 PM For Next Trading Session Pivots Classic Fibonacci Camarilla Woodie DM R3 31.66 31.13 29.61 - - R2 31.13 30.56 29.48 31.03 - R1 30.16 30.2 29.34 29.96 30.65 P 29.63 29.63 29.63 29.53 29.88 S1 28.66 29.06 29.06 28.46 29.15 S2 28.13 28.7 28.93 28.03 - S3 27.16 28.13 28.79 - - Morepen Laboratories Ltd Profit & Loss Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 INCOME 329.96 369.44 401.31 490.31 614.48 606.76 792.09 872.78 1241.71 1567.18 PROFIT -23.6 -5.66 2.14 17.2 23.63 29.59 28.85 33.58 97.09 101.68 EPS 0 0 0.05 0.28 0.53 0.66 0.64 0.75 2.16 2.13 Morepen Laboratories Ltd Profit & Loss Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 INCOME 307.48 338.05 369.55 458.1 565.67 560.13 740.37 808.99 1166.17 1457.77 PROFIT -25.75 -9.06 0.58 20.18 23.17 26.12 28.61 32.33 94.25 101.06 EPS 0 0 0.01 0.35 0.52 0.58 0.64 0.72 2.1 2.12 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar...

Morepen Laboratories Ltd.: Share Price, Stock Analysis, Annual Report | Value Research Morepen Laboratories Ltd.: Share Price, Stock Analysis, Annual Report | Value Research https://www.valueresearchonline.com/stocks/43354/morepen-laboratories-ltd/ Get Morepen Laboratories Ltd.'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house. Business Morepen Laboratories Limited operates as a pharmaceutical and healthcare products company in India. The company manufactures active pharmaceutical ingredients (APIs), home diagnostics, formulations, and over the counter products. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic drugs, anti- coagulant, anti-gout, and anti- malarial drugs; and home diagnostic products, such as air purifiers, sphygmomanometer, thermometers, stethoscopes, blood pressure monitors, pulse-oximeters, nebulizers, glucometers, blood glucose test strips, and heat belt. It also provides Burnol, first degree/minor burns cream; Fiber-X, a sat isabgol; fever X for fever; Pain X for pain; Acidity X for acidity; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti- allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals. The company offers its over-the-counter products under the Dr. Morepen brand. It also exports its products. Morepen Laboratories Limited was incorpora...

• Markets • Forecast • • • Top 5 Crypto forecasts • • • • • • • • Top 5 Stock forecasts • • • • • • • • Top 5 BSE Stock Forecasts • • • • • • • • Top 5 LSE Stock Forecasts • • • • • • • • • Top 5 Forex forecasts • • • • • • • • Top 5 Real Estate forecasts • • • • • • • • Top 5 Commodity Forecasts • • • • • • • • Top 5 Fund forecasts • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • Advertise • Login • • • • At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Morepen Laboratories Ltd. (Morepen Laboratories Ltd). If you are looking for stocks with good return, Morepen Laboratories Ltd. can be a profitable investment option. Morepen Laboratories Ltd. quote is equal to 29.200 INR at 2023-06-17. Based on our forecasts, a long-term increase is expected, the "Morepen Laboratories Ltd" stock price prognosis for 2028-06-09 is 43.521 INR. With a 5-year investment, the revenue is expected to be around +49.05%. Your current $100 investment may be up to $149.05 in 2028. Date Price Min Price Max Price 2023-06-19 Price: 29.100 Min: 28.166 Max: 30.002 2023-06-20 Price: 29.293 Min: 28.348 Max: 30.212 2023-06-21 Price: 29.611 Min: 28.734 Max: 30.515 2023-06-22 Price: 30.153 Min: 29.299 Max: 31.116 2023-06-23 Price: 29.923 Min: 29.032 Max: 30.819 2023-06-26 Price: 29.823 Min: 28.945 Max: 30.631 2023-06-27 Price: 30.016 Min: 29.128 Max: 30.920 2023-06-28 Price: ...

Q4FY23 Quarterly Result Announced for Morepen Laboratories Ltd. Pharmaceuticals company Morepen Laboratories announced Q4FY23 results: • Company has got three landmark recognitions in last three months including one USFDA approval, one PMDA inspection and one ISO13485 Approval • During the current Quarter Q4FY23, the business has stabilised and the consolidated revenues at Rs 367 crore against Rs 372 crore in the same quarter last year. • Annual revenues of Rs 1,424 crore have also paced a CAGR of 18% though in the current year revenues of all segments maintained a steady position except Medical Devices. • Medical devices business which peaked during covid due to increased demand and inventory buildup has also stabilized in last quarters and is on upward journey. In FY23 the gross revenues at Rs 327 crore were 22% lower than peek of Rs 418 crore in FY22 • Formulation Business has catching fast and has registered a jump of 28% in this Quarter. • Enhanced focus on marketing and advertising activities for better reach and brand recall, has affected the profitability levels. Description • Morepen Laboratories Limited is an India-based pharmaceutical company. Its products include Loratadine, Montelukast Sodium, Atorvastatin Calcium and Sultamicillin. The company markets formulation products in various therapeutic categories, such as antibiotics, gastrointestinal, respiratory, analgesic, antiallergic and neuropsychiatry with brands, such as Saltum, Saltumax, Cefpopen, Cefpen-S, ...

• Stock Returns vs Nifty Smallcap 100 Stock gave a 3 year return of -8.46% as compared to Nifty Smallcap 100 which gave a return of 141.48%. (as of last trading session) • Stock Returns vs Nifty Pharma Stock generated -8.46% return as compared to Nifty Pharma which gave investors 32.58% return over 3 year time period. (as of last trading session) NAME P/E (x) P/B (x) ROE % ROCE % ROA % Rev CAGR [3Yr] OPM NPM Basic EPS Current Ratio Total Debt/ Equity (x) Total Debt/ CFO (x) 38.59 1.98 5.13 7.31 3.48 17.98 4.07 2.72 0.77 2.35 0.03 0.00 28.19 6.46 22.91 20.06 9.25 21.46 16.64 11.54 8.22 1.61 0.90 0.00 19.75 2.63 13.32 14.22 10.51 -2.68 30.92 27.29 41.86 4.25 0.00 0.00 -66.19 0.34 -0.51 1.03 -0.31 5.28 3.28 -1.23 -1.90 1.07 0.31 0.00 -15.74 2.53 -17.33 -3.72 -7.92 6.20 -2.62 -8.58 -4.88 1.50 0.57 0.00 Add More • Stock Returns vs Nifty Smallcap 100 Stock gave a 3 year return of -8.46% as compared to Nifty Smallcap 100 which gave a return of 141.48%. (as of last trading session) • Stock Returns vs Nifty Pharma Stock generated -8.46% return as compared to Nifty Pharma which gave investors 32.58% return over 3 year time period. (as of last trading session) Meeting Date Announced on Purpose Details May 16, 2023 May 09, 2023 Board Meeting Audited Results Feb 13, 2023 Feb 06, 2023 Board Meeting Quarterly Results Nov 10, 2022 Nov 03, 2022 Board Meeting Quarterly Results Jul 29, 2022 Jul 22, 2022 Board Meeting Quarterly Results May 05, 2022 Apr 28, 2022 Board Meeting Audited Results •...

Morepen Laboratories Ltd.: Share Price, Stock Analysis, Annual Report | Value Research Morepen Laboratories Ltd.: Share Price, Stock Analysis, Annual Report | Value Research https://www.valueresearchonline.com/stocks/43354/morepen-laboratories-ltd/ Get Morepen Laboratories Ltd.'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house. Business Morepen Laboratories Limited operates as a pharmaceutical and healthcare products company in India. The company manufactures active pharmaceutical ingredients (APIs), home diagnostics, formulations, and over the counter products. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic drugs, anti- coagulant, anti-gout, and anti- malarial drugs; and home diagnostic products, such as air purifiers, sphygmomanometer, thermometers, stethoscopes, blood pressure monitors, pulse-oximeters, nebulizers, glucometers, blood glucose test strips, and heat belt. It also provides Burnol, first degree/minor burns cream; Fiber-X, a sat isabgol; fever X for fever; Pain X for pain; Acidity X for acidity; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti- allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals. The company offers its over-the-counter products under the Dr. Morepen brand. It also exports its products. Morepen Laboratories Limited was incorpora...

STOCK SUMMARY • Face Value (₹) 2.00 • Beta 0.27 • 52-Week Low (₹) 23.60 • 52-Week High (₹) 48.45 • Price-to-Book (X)* 1.98 • Dividend Yield (%) 0.00 • Price-to-Earnings (P/E) (X)* 38.42 • Earnings Per Share (₹) 0.76 • Sector Price Earning (X)* 30.49 • Market Cap (₹ Cr.)* 1,492.61 • * Vaues as of last close price COMPETITORS • Aurobindo Pharma ₹682.60 -2.80 (0.41%) • Torrent Pharmaceuticals ₹1,858.20 19.00 (1.03%) • Alkem Laboratories ₹3,398.95 4.55 (0.13%) • Lupin ₹830.45 -4.30 (0.52%) • Glaxosmithkline Pharmaceuticals ₹1,419.20 17.70 (1.26%) • Dr Reddys Laboratories ₹4,915.05 111.60 (2.32%) • Zydus Lifesciences ₹551.05 1.90 (0.35%) The peers of Morepen Laboratories Ltd are Aurobindo Pharma Ltd, Torrent Pharmaceuticals Ltd, Alkem Laboratories Ltd, Lupin Ltd, Glaxosmithkline Pharmaceuticals Ltd, Dr Reddys Laboratories Ltd, Zydus Lifesciences Ltd, Cipla Ltd, Biocon Ltd, Syngene International Ltd, Laurus Labs Ltd, Divis Laboratories Ltd, Ajanta Pharma Ltd, Sun Pharmaceuticals Industries Ltd. Morepen Laboratories Ltd, incorporated in the year 1984, has its registered office in Morepen Village, Nalagarh Road Near Baddi, Solan, Himachal Pradesh, 173205, 91-01795-276201-03, 91-01795-276204. The main industry in which Morepen Laboratories Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln. Auditor/Auditors for Morepen Laboratories Ltd is/are Satinder Goyal & Co/S P Babuta & Associates. In the main management, Sushil Suri is chairman and Vipul Kumar Srivatava is the com...